126 related articles for article (PubMed ID: 36445513)
1. Progesterone regulates the endoplasmic reticulum-associated degradation and Unfolded Protein Response axis by mimicking the androgenic stimulation in prostate cancer cells.
Erzurumlu Y; Dogan HK; Catakli D
Mol Biol Rep; 2023 Feb; 50(2):1253-1265. PubMed ID: 36445513
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine positively regulates endoplasmic reticulum-associated degradation (ERAD) and promotes androgenic signaling in androgen-dependent prostate cancer cells.
Erzurumlu Y; Muhammed MT
Cell Signal; 2023 Sep; 109():110745. PubMed ID: 37271348
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)
Erzurumlu Y; Aydogdu E; Dogan HK; Catakli D; Muhammed MT; Buyuksandic B
Cell Signal; 2023 Mar; 103():110577. PubMed ID: 36567009
[TBL] [Abstract][Full Text] [Related]
4. Estrogens drive the endoplasmic reticulum-associated degradation and promote proto-oncogene c-Myc expression in prostate cancer cells by androgen receptor/estrogen receptor signaling.
Erzurumlu Y; Dogan HK; Catakli D; Aydogdu E; Muhammed MT
J Cell Commun Signal; 2023 Sep; 17(3):793-811. PubMed ID: 36696010
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-stimulated glucocorticoid receptor signaling positively regulates the endoplasmic reticulum-associated degradation (ERAD) mechanism in hepatocellular carcinoma cells.
Erzurumlu Y; Dogan HK; Cataklı D
Steroids; 2023 Jul; 195():109238. PubMed ID: 37044236
[TBL] [Abstract][Full Text] [Related]
6. Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer.
Erzurumlu Y; Ballar P
Sci Rep; 2017 Jan; 7():40719. PubMed ID: 28091582
[TBL] [Abstract][Full Text] [Related]
7. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
8. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
[TBL] [Abstract][Full Text] [Related]
9. Divergent androgen regulation of unfolded protein response pathways drives prostate cancer.
Sheng X; Arnoldussen YJ; Storm M; Tesikova M; Nenseth HZ; Zhao S; Fazli L; Rennie P; Risberg B; Wæhre H; Danielsen H; Mills IG; Jin Y; Hotamisligil G; Saatcioglu F
EMBO Mol Med; 2015 Jun; 7(6):788-801. PubMed ID: 25864123
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
11. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
12. New mode of action of curcumin on prostate cancer cells: Modulation of endoplasmic reticulum-associated degradation mechanism and estrogenic signaling.
Erzurumlu Y; Dogan HK; Catakli D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23636. PubMed ID: 38229314
[TBL] [Abstract][Full Text] [Related]
13. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
14. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
15. Quality Control in the Endoplasmic Reticulum: Crosstalk between ERAD and UPR pathways.
Hwang J; Qi L
Trends Biochem Sci; 2018 Aug; 43(8):593-605. PubMed ID: 30056836
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
17. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
Attardi BJ; Burgenson J; Hild SA; Reel JR
Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
[TBL] [Abstract][Full Text] [Related]
19. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo.
Petiwala SM; Li G; Bosland MC; Lantvit DD; Petukhov PA; Johnson JJ
Carcinogenesis; 2016 Aug; 37(8):827-838. PubMed ID: 27267997
[TBL] [Abstract][Full Text] [Related]
20. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]